×
About 4,607 results

ALLMedicine™ Chondrosarcoma Center

Research & Reviews  2,275 results

Chondrosarcoma of the hands and feet.
https://doi.org/10.1302/0301-620X.103B3.BJJ-2020-1337.R1
The Bone & Joint Journal; Kask G, Laitinen MK et. al.

Mar 1st, 2021 - A multicentre retrospective study was carried out at two tertiary sarcoma centres. A database search identified all patients with a CS treated between January 1995 and January 2018. There were 810 CSs of which 76 (9.4%) were located in the fingers...

Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and c...
https://doi.org/10.1016/j.radonc.2021.02.012
Radiotherapy and Oncology : Journal of the European Socie... De Leo AN, Holtzman AL et. al.

Feb 21st, 2021 - Dose escalation for skull-based chordoma and chondrosarcoma can put critical adjacent structures at risk, specifically the anterior optic pathway. We report the incidence of vision loss following high-dose conformal proton-based radiotherapy. We r...

Incidence, Management, and Outcomes of Adult Spinal Chondrosarcoma Patients in the Unit...
https://doi.org/10.1016/j.wneu.2021.02.030
World Neurosurgery; Nunna RS, Patel S et. al.

Feb 18th, 2021 - Spinal chondrosarcomas are rare primary malignant neoplasms composed of cartilage-producing cells. They are slow growing but locally aggressive lesions that have high rates of recurrence and progression after treatment. Here we provide the largest...

Chondrosarcoma.
https://doi.org/10.5435/JAAOS-D-20-01188
The Journal of the American Academy of Orthopaedic Surgeons; Weinschenk RC, Wang WL et. al.

Feb 17th, 2021 - Chondrosarcoma is the second most common primary bone tumor, with >90% of cases representing the primary conventional subtype. In addition to arising de novo, conventional chondrosarcoma can arise secondary to a benign underlying lesion, such as e...

Dedifferentiated chondrsarcoma: a clinicopathologic analysis of 25 cases.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885579
BMC Musculoskeletal Disorders; Cao L, Wu Y et. al.

Feb 16th, 2021 - To investigate the clinical, imaging and pathological features of dedifferentiated chondrosarcoma for better diagnosis. Patients who had been confirmed to have dedifferentiated chondrosarcoma were enrolled in this study and analyzed in the clinica...

see more →

Guidelines  1 results

NCCN Guidelines Insights: Bone Cancer, Version 2.2017
http://www.jnccn.org/content/15/2/155.full
Biermann, J.,et al

Jan 31st, 2017 - The NCCN Guidelines for Bone Cancer provide interdisciplinary recommendations for treating chordoma, chondrosarcoma, giant cell tumor of bone, Ewing sarcoma, and osteosarcoma. These NCCN Guidelines Insights summarize the NCCN Bone Cancer Panel's g.

see more →

Clinicaltrials.gov  2,303 results

Chondrosarcoma of the hands and feet.
https://doi.org/10.1302/0301-620X.103B3.BJJ-2020-1337.R1
The Bone & Joint Journal; Kask G, Laitinen MK et. al.

Mar 1st, 2021 - A multicentre retrospective study was carried out at two tertiary sarcoma centres. A database search identified all patients with a CS treated between January 1995 and January 2018. There were 810 CSs of which 76 (9.4%) were located in the fingers...

Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and c...
https://doi.org/10.1016/j.radonc.2021.02.012
Radiotherapy and Oncology : Journal of the European Socie... De Leo AN, Holtzman AL et. al.

Feb 21st, 2021 - Dose escalation for skull-based chordoma and chondrosarcoma can put critical adjacent structures at risk, specifically the anterior optic pathway. We report the incidence of vision loss following high-dose conformal proton-based radiotherapy. We r...

Incidence, Management, and Outcomes of Adult Spinal Chondrosarcoma Patients in the Unit...
https://doi.org/10.1016/j.wneu.2021.02.030
World Neurosurgery; Nunna RS, Patel S et. al.

Feb 18th, 2021 - Spinal chondrosarcomas are rare primary malignant neoplasms composed of cartilage-producing cells. They are slow growing but locally aggressive lesions that have high rates of recurrence and progression after treatment. Here we provide the largest...

Chondrosarcoma.
https://doi.org/10.5435/JAAOS-D-20-01188
The Journal of the American Academy of Orthopaedic Surgeons; Weinschenk RC, Wang WL et. al.

Feb 17th, 2021 - Chondrosarcoma is the second most common primary bone tumor, with >90% of cases representing the primary conventional subtype. In addition to arising de novo, conventional chondrosarcoma can arise secondary to a benign underlying lesion, such as e...

Dedifferentiated chondrsarcoma: a clinicopathologic analysis of 25 cases.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885579
BMC Musculoskeletal Disorders; Cao L, Wu Y et. al.

Feb 16th, 2021 - To investigate the clinical, imaging and pathological features of dedifferentiated chondrosarcoma for better diagnosis. Patients who had been confirmed to have dedifferentiated chondrosarcoma were enrolled in this study and analyzed in the clinica...

see more →

News  11 results

Cancer Survivors’ Risk of Mood Disorders
https://www.mdedge.com/fedprac/avaho/article/189222/mental-health/cancer-survivors-risk-mood-disorders

Nov 26th, 2018 - Cancer survivors have a higher risk of depression within 2 years after the diagnosis, according to a meta-analysis. But is that true of survivors of all types of cancer? In fact, risk is multifactorial because patients, cancers, comorbidities, and.

Epidemiology and Survivorship of Chondrosarcoma in the United States: An Analysis of the National Cancer Database
https://www.mdedge.com/fedprac/avaho/article/175095/mixed-topics/epidemiology-and-survivorship-chondrosarcoma-united-states
Kang BY, Gonzaga I et. al.

Sep 18th, 2018 - Background: Chondrosarcoma (CHS) is the second most common primary malignant solid bone tumor. Present management of CHS is based largely on case series from individual treatment centers.

Potential New Targeted Treatment for Chondrosarcoma
https://www.mdedge.com/fedprac/article/109688/oncology/potential-new-targeted-treatment-chondrosarcoma
Jan Dyer

Jun 16th, 2016 - The gene BIRC5 is an “important player” in chondrosarcoma survival, say researchers from Leiden University, The Netherlands, and Athens University, Greece. They propose that targeting survivin, a protein encoded by BIRC5, could lead to a potential.

Nonoperative Management of Multiple Hand Enchondromas in Ollier Disease With Progressive Ossification
https://www.mdedge.com/surgery/article/102383/hand-wrist/nonoperative-management-multiple-hand-enchondromas-ollier-disease/page/0/2?channel=264

Sep 1st, 2015 - Histologic analysis of biopsied or surgically treated lesions contributes to the differentiation between benign hand enchondromas and chondrosarcoma. Pathologic findings must be correlated with clinical and radiographic findings because hand encho.

Giant Solitary Synovial Chondromatosis Mimicking Chondrosarcoma: Report of a Rare Histologic Presentation and Literature Review
https://www.mdedge.com/surgery/article/101687/hip/giant-solitary-synovial-chondromatosis-mimicking-chondrosarcoma-report/page/0/2?channel=264

Aug 4th, 2015 - The original idea that SCM originates from a metaplasia in the subintimal layer of the synovium, where the synovium is in direct contact with the articular cartilage, has been challenged. The high incidence of hypercellularity, binucleated cells,.

see more →

Patient Education  17 results see all →